Sponsored by:

Nuclear Medicine: Page 251

Contrast MRI evaluates myocardial viability in patients with ICDs
By Wayne Forrest
Researchers from the University of Maryland in Baltimore have found that contrast-enhanced MRI and FDG-PET can help in the accurate differentiation between viable and nonviable myocardium in patients with implantable cardioverter-defibrillator (ICD) devices undergoing ventricular tachycardia ablations.
October 4, 2010
Naviscan adds Texas client
By AuntMinnie.com staff writers
PET developer Naviscan has added SightLine Health in Houston to its customer list.
October 3, 2010
SNM changes name, course of MICoE
By AuntMinnie.com staff writers
SNM's Molecular Imaging Center of Excellence (MICoE) has changed its name to the Center for Molecular Imaging Innovation and Translation to reflect the group's new mission.
October 3, 2010
FLT-PET technique targets ovarian cancer
By AuntMinnie.com staff writers
A molecular imaging technique that uses F-18 fluorothymidine (FLT) may prove useful in the early assessment of treatment response for cisplatin-resistant ovarian cancer, according to a study in the October issue of the Journal of Nuclear Medicine.
October 3, 2010
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
October 3, 2010
EANM issues radiation therapy rules for PET
By AuntMinnie.com staff writers
The European Association of Nuclear Medicine (EANM) has released new guidelines for PET scanning in oncology radiation therapy.
September 30, 2010
ACRIN scores AHRQ grant
By AuntMinnie.com staff writers
The American College of Radiology Imaging Network (ACRIN) has been awarded a grant by the Agency for Healthcare Research and Quality (AHRQ) to compare the outcomes of patients with stable angina using two different imaging methods.
September 29, 2010
Naviscan touts PEM study results
By AuntMinnie.com staff writers
PET developer Naviscan is touting the results of a prospective study that concluded that positron emission mammography (PEM) and breast MRI had comparably high efficacy in detecting cancerous lesions.
September 27, 2010
FDG-PET/CT viability scans detect vulnerable aortic plaque
By Wayne Forrest
Canadian researchers have found that detecting vulnerable aortic plaque with conventional FDG-PET/CT myocardial viability studies is feasible, according to a presentation at the American Society of Nuclear Cardiology annual meeting in Philadelphia.
September 26, 2010
2010 09 27 09 17 20 380 Asnc Pet Ct Plaque 01 Thumb
MDS inks Russian Mo-99 deal
By AuntMinnie.com staff writers
MDS Nordion has entered into an agreement with a Russian company to develop, market, and sell molybdenum-99 (Mo-99) radioisotopes produced in Russia.
September 22, 2010
NTP uses LEU for Mo-99 production
By AuntMinnie.com staff writers
NTP Radioisotopes of South Africa reportedly is perfecting the use of low-enriched uranium (LEU) at its Safari-1 nuclear reactor to produce the medical isotope molybdenum-99 (Mo-99).
September 20, 2010
European reactor operators form alliance
By AuntMinnie.com staff writers
The Nuclear Research and Consultancy Group has joined the French Alternative Energies and Atomic Energy Commission and the Belgian Nuclear Research Centre to create the European Research Area of Experimental Reactors.
September 20, 2010
Previous Page
Page 251 of 440
Next Page